01
Biotechnology
Platforms, therapeutics and tools grounded in credible science and meaningful clinical potential.
Early-stage venture capital
Backing founders who build what matters next.
I invest in ambitious founders at the intersection of science, technology and long-term societal value.
Scroll to explore
Seed → Series A
Primary investment stage
4
Core sectors
Long-term
Founder and value orientation
About
Capital with conviction.
I believe the best investments begin with clarity of thought, scientific integrity and founders who keep moving when the path is not obvious.
Lori is a Senior Associate at Crosscut Ventures in Santa Monica. She focuses on early-stage opportunities in biotechnology, frontier technology, climate technology and clean energy, with an emphasis on founder quality, scalability and durable impact.
Investment focus
Where rigorous science meets scalable ambition.
I look for markets where technical breakthroughs can become enduring companies.
02
Frontier Technology
Deep technical innovation that can reshape infrastructure, industry and human capability.
03
Climate Technology
Solutions that deliver measurable environmental impact alongside compelling unit economics.
04
Clean Energy
Technologies improving how energy is generated, stored, distributed and consumed.
Experience
A career shaped by investing, learning and rebuilding.
Present
Crosscut Ventures · Senior Associate
Early-stage investing across science-led and technology-driven categories.
2020
Crosscut Ventures · Venture Capital Director
Promoted to lead venture investment after two years managing the venture capital team.
2018
Crosscut Ventures · Venture Capital Team Lead
Promoted to lead the venture capital team after three years with the firm.
2015
Crosscut Ventures
Joined the firm to evaluate and support early-stage companies across emerging technology sectors.
2012–2014
Drexel University · MBA
Advanced business training with a focus on strategy, finance and leadership.
2012
Drexel University · LeBow College of Business
Undergraduate foundation in business and finance.
Investment principles
What I value before the numbers become obvious.
01
Founder integrity
Intellectual honesty, resilience and the ability to attract exceptional people.
02
Evidence before narrative
Especially in science-led companies, validation matters more than a polished pitch.
03
Scale with substance
Large markets matter, but only when the product creates durable and defensible value.
Contact
Building something ambitious?
I welcome thoughtful conversations with founders, operators and long-term partners.